Katherine (Katie) R. Reaves’ practice focuses on debt finance transactions.

She regularly represents leading companies, private equity sponsors, and their portfolio companies in connection with a variety of secured lending and other corporate finance transactions, including acquisition financings, high-yield bond issuances, bridge facilities, syndicated credit facilities, and ABL facilities.

Katie joined the firm in 2010 and became partner in 2019.

Notable Experience

  • Warburg Pincus, GTCR, and their portfolio company Sotera Health in connection with the financing for the pending acquisition of certain assets of Iotron Industries.

  • Cushman & Wakefield in connection with the refinancing of its credit facilities and its subsequent offering of senior secured notes.

  • Honeywell International in connection with its delayed draw term loan facility.

  • Warburg Pincus, Berkshire Partners, and their portfolio company Consolidated Precision Products in connection with the establishment of platform for the sale of trade receivables.

  • American Express in connection with amendments to its co-brand credit card arrangement with Marriott.

  • Warburg Pincus, GTCR, and their portfolio company Sotera Health in connection with the refinancing of its credit facilities, redemption of its outstanding notes, and financing for a dividend recapitlaization.

  • Warburg Pincus and its portfolio company CityMD in connection with the acquisition of Summit Medical Group.

  • Warburg Pincus and its portfolio company Consolidated Precision Products in connection with a recapitalization transaction with Berkshire Partners.

  • ESL Investments in connection with the financing of its $5.2 billion acquisition of Sears in the Section 363 sale of assets and numerous subsequent financings to its portfolio company Transform Midco.

  • Honeywell International in the senior secured credit facilities and high-yield bond financings for its spin-off of Garrett Motion.

  • General Mills Inc. in connection with the financing of its $8 billion acquisition of Blue Buffalo Pet Products.

  • Cushman & Wakefield in connection with the negotiation of its $3.51 billion senior secured credit facilities following its IPO.

  • Warburg Pincus and its portfolio company Consolidated Precision Products in connection with the refinancing of its senior secured credit facilities and the financing of its subsequent acquisitions of Selmet Inc and Poly 6.

  • McCormick & Co. in connection with the financing of its $4.2 billion acquisition of the food business of Reckitt Benckiser Group Plc.

  • Warburg Pincus, GTCR, and their portfolio company Sotera Health in an offering of PIK-toggles notes and in the financing for the acquisition of Nelson Laboratories and Toxikon Europe.

  • Samsonite in connection with the financing of its $1.8 billion acquisition of Tumi.

  • Port Newark Container Terminal in connection with the project financing of its terminal development project at Port Newark.

  • Endurance International Group in its $1.1 billion acquisition of Constant Contact.

  • Brookfield Asset Management in the refinancing of Capital Automotive’s credit facilities.

  • Warburg Pincus in the financing of various acquisitions, including its acquisition of:

    • Duravant,
    • CityMD,
    • Sotera Health (f/k/a Sterigenics), and
    • Rural/Metro.
  • TPG Capital in the financing of various acquisitions, including its acquisition of:

    • Envision Pharmaceuticals and its subsequent $2 billion sale to Rite Aid; and
    • DTZ (alongside PAG and Ontario Teachers’ Pension Plan), and in DTZ’s subsequent acquisitions of Cassidy Turley and Cushman & Wakefield.
  • MacAndrews & Forbes and its portfolio company Harland Clarke in its $1.8 billion acquisition of Valassis.

  • Biome and its four private equity consortium owners – Blackstone, Goldman Sachs PIA, KKR, and TPG – in Biomet’s $13.35 billion cash and stock merger with Zimmer Holdings.

  • Investment-grade revolving credit facilities for investment-grade borrowers, including Alphabet Inc., Honeywell International, and McCormick & Co.

  • Kraton Polymers in its $1.37 billion acquisition of Arizona Chemical Holdings, and in the refinancing of its existing credit facilities.

See More

Publications